Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder

The Journal of Pharmacology and Experimental Therapeutics
Pascal BonaventureTimothy W Lovenberg

Abstract

In rodents 5-hydroxytryptamine type 7 (5-HT(7)) receptor blockade has been shown to be effective in models of depression and to increase the latency to rapid eye movement (REM) sleep and decrease REM duration. In the clinic, the REM sleep reduction observed with many antidepressants may serve as a biomarker. We report here the preclinical and clinical evaluation of a 5-HT(7) receptor antagonist, (3-(4-chlorophenyl)-1,4,5,6,7,8-hexahydro-1-(phenylmethyl)pyrazolo[3,4-d]azepine 2-hydroxy-1,2,3-propanetricarboxylate) (JNJ-18038683). In rodents, JNJ-18038683 increased the latency to REM sleep and decreased REM duration, and this effect was maintained after repeated administration for 7 days. The compound was effective in the mouse tail suspension test. JNJ-18038683 enhanced serotonin transmission, antidepressant-like behavior, and REM sleep suppression induced by citalopram in rodents. In healthy human volunteers JNJ-18038683 prolonged REM latency and reduced REM sleep duration, demonstrating that the effect of 5-HT(7) blockade on REM sleep translated from rodents to humans. Like in rats, JNJ-18038683 enhanced REM sleep suppression induced by citalopram in humans, although a drug-drug interaction could not be ruled out. In a double-...Continue Reading

References

Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson
Jan 15, 1995·Biological Psychiatry·A L Sharpley, P J Cowen
May 1, 1997·Acta Psychiatrica Scandinavica·R L O'SullivanJ F Rosenbaum
Aug 24, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·U L MullinsA S Eison
May 12, 2000·British Journal of Pharmacology·D R ThomasG W Price
May 24, 2000·British Journal of Pharmacology·J J HaganD R Thomas
Jan 17, 2003·Proceedings of the National Academy of Sciences of the United States of America·P B HedlundJ G Sutcliffe
May 24, 2003·Neuropharmacology·M R GuscottP H Hutson
Jun 19, 2003·British Journal of Pharmacology·David R ThomasIan T Forbes
Mar 23, 2004·European Journal of Pharmacology·Peter B HedlundPascal Bonaventure
Jul 16, 2005·Biological Psychiatry·Peter B HedlundJ Gregor Sutcliffe
Jan 29, 2008·Sleep·Stephen R MorairtyThomas S Kilduff
Dec 1, 2010·The Journal of Clinical Psychiatry·Stephen M Stahl
Feb 18, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ouissame Mnie-FilaliNasser Haddjeri
Mar 23, 2011·Molecular Neurobiology·Anne MatthysPeter Vanhoenacker
May 31, 2011·European Journal of Medicinal Chemistry·Julien AndriesThierry Billard
Jun 9, 2011·Current Medicinal Chemistry·D MarazzitiF Borsini
Jul 26, 2011·Current Opinion in Pharmacology·Emilio Merlo Pich

❮ Previous
Next ❯

Citations

Sep 18, 2013·Experimental Brain Research·Evelien GellynckKathleen Van Craenenbroeck
Feb 26, 2004·Bioorganic & Medicinal Chemistry Letters·Jill A JablonowskiNicholas I Carruthers
Aug 28, 2015·Expert Review of Neurotherapeutics·Sheng-Min WangChi-Un Pae
Jul 13, 2014·Pharmacology & Therapeutics·Connie SanchezFrancesc Artigas
Jun 18, 2014·CNS Neuroscience & Therapeutics·Vladimir S NaumenkoEvgeni G Ponimaskin
Sep 19, 2014·Journal of Pharmacological Sciences·Takeshi MuraiKazuhito Ikeda
Feb 17, 2018·ChemMedChem·Ali AtesCéline Vermeiren
Nov 21, 2018·Expert Opinion on Drug Discovery·Xenia GondaFrank I Tarazi
Apr 19, 2017·CNS Neuroscience & Therapeutics·Sarah DelcourteNasser Haddjeri
Oct 4, 2019·European Journal of Medicinal Chemistry·Sangeetha-Laura ThirumaranChristophe Rochais
Aug 26, 2020·Progress in Neurobiology·Josephine LabusEvgeni Ponimaskin
Feb 19, 2013·Neuropharmacology·Lindsay N CatesPeter B Hedlund
Jul 27, 2021·Bioorganic & Medicinal Chemistry Letters·Katarzyna Kucwaj-BryszJadwiga Handzlik
Jun 12, 2020·Neuropharmacology·Trevor Sharp, Nicholas M Barnes
Jul 22, 2018·Journal of Medicinal Chemistry·Youngjae KimHyunah Choo
Jul 30, 2014·Journal of Medicinal Chemistry·Rocío A MedinaMaría L López-Rodríguez
May 17, 2018·Journal of Medicinal Chemistry·Maria N ModicaMarcello Leopoldo
Aug 28, 2021·International Journal of Molecular Sciences·Grzegorz ŚlifirskiJadwiga Turło

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.